EDU [New Oriental Education & Technology] UPLOAD: (Original Filing)
[]
CO [China Cord Blood] SC 13G: (Original Filing)
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]
CO [China Cord Blood] SC 13G: *The remainder of this cover page shall be
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]
ZX [China Zenix Auto International] 6-K: (Original Filing)
[China Zenix Filed Annual Report on Form 20-F for 2011 ZHANGZHOU, China, April 26, 2012 China Zenix Auto International Limited About China Zenix Auto International Limited China Zenix Auto International Limited is the largest commercial vehicle wheel manufacturer in China in both the aftermarket and OEM market by sales volume. With a large intellectual property portfolio, the Company offers]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8: (Original Filing)
[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-8:
[] [[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California]
